Baird Medical Expands Global MWA Training with Expert-Led Program in Guangzhou
Baird Medical Investment Holdings (NASDAQ: BDMD) hosted a delegation of Bangladeshi physicians at its Guangzhou headquarters for an expert-led microwave ablation (MWA) training program. The delegation included four doctors who participated in theoretical discussions and hands-on demonstrations at Baird's facility.
The training continued at Sun Yat-sen University Cancer Center, where participants observed live MWA procedures for liver and lung ablations, followed by discussions with specialists. The program concluded with a session on thyroid microwave ablation techniques led by Dr. Feng Han in the hospital's Ultrasound Department.
Chairwoman Haimei Wu emphasized the company's commitment to global knowledge-sharing and medical innovation through cross-border collaboration.
Baird Medical Investment Holdings (NASDAQ: BDMD) ha ospitato una delegazione di medici bengalesi presso la sua sede di Guangzhou per un programma di formazione sulla ablazione a microonde (MWA) guidato da esperti. La delegazione era composta da quattro medici che hanno partecipato a discussioni teoriche e dimostrazioni pratiche presso la struttura di Baird.
La formazione è proseguita presso il Centro Oncologico dell'Università Sun Yat-sen, dove i partecipanti hanno osservato procedure MWA dal vivo per ablazioni del fegato e dei polmoni, seguite da discussioni con specialisti. Il programma si è concluso con una sessione sulle tecniche di ablazione a microonde della tiroide condotta dal Dr. Feng Han nel Dipartimento di Ultrasuoni dell'ospedale.
La presidente Haimei Wu ha sottolineato l'impegno dell'azienda nella condivisione globale delle conoscenze e nell'innovazione medica attraverso la collaborazione transfrontaliera.
Baird Medical Investment Holdings (NASDAQ: BDMD) recibió a una delegación de médicos bangladesíes en su sede de Guangzhou para un programa de capacitación en ablación por microondas (MWA) dirigido por expertos. La delegación incluyó a cuatro médicos que participaron en discusiones teóricas y demostraciones prácticas en las instalaciones de Baird.
La capacitación continuó en el Centro Oncológico de la Universidad Sun Yat-sen, donde los participantes observaron procedimientos MWA en vivo para ablaciones de hígado y pulmones, seguidos de discusiones con especialistas. El programa concluyó con una sesión sobre técnicas de ablación por microondas de tiroides dirigida por el Dr. Feng Han en el Departamento de Ultrasonido del hospital.
La presidenta Haimei Wu enfatizó el compromiso de la empresa con el intercambio global de conocimientos y la innovación médica a través de la colaboración transfronteriza.
베어드 메디컬 인베스트먼트 홀딩스 (NASDAQ: BDMD)는 광저우 본사에서 방글라데시 의사 대표단을 초청하여 전문가 주도의 마이크로파 절제(MWA) 교육 프로그램을 진행했습니다. 이 대표단에는 이론 토론과 베어드 시설에서의 실습 시연에 참여한 네 명의 의사가 포함되었습니다.
교육은 선양센 대학교 암 센터에서 계속되었으며, 참가자들은 간과 폐 절제술을 위한 MWA 시술을 실시간으로 관찰하고 전문가들과의 토론을 진행했습니다. 프로그램은 병원 초음파 부서에서 펑 한 박사가 이끄는 갑상선 마이크로파 절제 기술 세션으로 마무리되었습니다.
회장 하이메이 우는 국경을 초월한 협력을 통해 글로벌 지식 공유와 의료 혁신에 대한 회사의 헌신을 강조했습니다.
Baird Medical Investment Holdings (NASDAQ: BDMD) a accueilli une délégation de médecins bangladais dans son siège à Guangzhou pour un programme de formation à l'ablation par micro-ondes (MWA) dirigé par des experts. La délégation comprenait quatre médecins qui ont participé à des discussions théoriques et à des démonstrations pratiques dans les installations de Baird.
La formation s'est poursuivie au Centre de Cancérologie de l'Université Sun Yat-sen, où les participants ont observé des procédures MWA en direct pour des ablations du foie et des poumons, suivies de discussions avec des spécialistes. Le programme s'est terminé par une session sur les techniques d'ablation par micro-ondes de la thyroïde animée par le Dr Feng Han au département d'échographie de l'hôpital.
La présidente Haimei Wu a souligné l'engagement de l'entreprise envers le partage des connaissances à l'échelle mondiale et l'innovation médicale à travers la collaboration transfrontalière.
Baird Medical Investment Holdings (NASDAQ: BDMD) hat eine Delegation von bangladeschischen Ärzten in seiner Zentrale in Guangzhou zu einem von Experten geleiteten Schulungsprogramm zur Mikrowellenablation (MWA) empfangen. Die Delegation bestand aus vier Ärzten, die an theoretischen Diskussionen und praktischen Demonstrationen in den Einrichtungen von Baird teilnahmen.
Die Schulung setzte sich im Krebszentrum der Sun Yat-sen-Universität fort, wo die Teilnehmer live MWA-Verfahren für Leber- und Lungenablationen beobachteten, gefolgt von Diskussionen mit Spezialisten. Das Programm endete mit einer Sitzung zu Techniken der Schilddrüsenmikrowellenablation, die von Dr. Feng Han in der Ultraschallabteilung des Krankenhauses geleitet wurde.
Vorsitzende Haimei Wu betonte das Engagement des Unternehmens für den globalen Wissensaustausch und medizinische Innovationen durch grenzüberschreitende Zusammenarbeit.
- Expanding international market presence through medical training programs
- Strengthening partnerships with major medical institutions
- Demonstrating technological leadership in MWA applications
- None.
The delegation included Dr. MD Mofazzal Sharif, Dr. Mohammad Rezaul Haque, Dr. Alamgir A.B.M., and Dr. Mohammad Jannatul Ferdous Rubel, who participated in a comprehensive training program designed to enhance their expertise in MWA techniques. The program's first day featured in-depth theoretical discussions and hands-on demonstrations at Baird Medical's state-of-the-art facility, providing participants with a deeper understanding of MWA applications in clinical practice.
On the second day, the delegation continued their training with a visit to Sun Yat-sen University Cancer Center, where they were warmly welcomed by Dr. Fujun Zhang, Director of the Belt and Road Training Base of the Chinese Anti-Cancer Association. The visit began with the observation of multiple live MWA procedures, including liver and lung ablations. Following these observations, the delegation engaged in a comprehensive discussion, exchanging insights and best practices with leading specialists in the field. To conclude the day, the group participated in an in-depth session on thyroid microwave ablation techniques, led by Dr. Feng Han in the hospital's Ultrasound Department, further deepening their understanding of the latest advancements in MWA technology.
"This program exemplifies our commitment to global knowledge-sharing and medical innovation," said Haimei Wu, Chairwoman of Baird Medical. "By fostering cross-border collaboration, we aim to advance MWA technology and elevate patient care on a global scale."
Baird Medical remains dedicated to equipping medical professionals worldwide with cutting-edge expertise, reinforcing its role as a leader in the advancement of MWA technology.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts and generally relate to future events or Baird Medical's future financial or operational performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue," or the negative of these terms or other similar expressions.
These forward-looking statements are subject to risks, uncertainties, and assumptions that could cause actual results or outcomes to differ materially from those expressed or implied. These statements are based on estimates and assumptions that, while considered reasonable by Baird Medical and its management, are inherently uncertain. Risks and uncertainties may emerge over time, and it is not possible to anticipate all potential factors that could affect Baird Medical's business and financial performance.
Factors that could cause actual results to differ materially include, but are not limited to: (1) the risk that Baird Medical may not achieve its expansion goals in
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Baird Medical undertakes no obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. All forward-looking statements in this press release are qualified in their entirety by this cautionary statement.
Contact:
Eric Huang, PR Liaison
Baird Medical Investment Holdings Ltd.
Phone: +1 (888) 508-6228
Email: ir@bairdmed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-expands-global-mwa-training-with-expert-led-program-in-guangzhou-302385619.html
SOURCE BDMD
FAQ
What was the purpose of BDMD's recent training program in Guangzhou?
Which medical procedures were demonstrated during BDMD's training at Sun Yat-sen University Cancer Center?
Who were the key participants in BDMD's MWA training program?
What facilities were involved in BDMD's MWA training program in February 2025?
